Cronos Group (CRON) Competitors $2.05 -0.02 (-0.97%) Closing price 04:00 PM EasternExtended Trading$2.07 +0.02 (+0.78%) As of 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRON vs. ACB, CGC, OGI, SNDL, TLRY, HCM, IMVT, KYMR, CRNX, and MORShould you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), HUTCHMED (HCM), Immunovant (IMVT), Kymera Therapeutics (KYMR), Crinetics Pharmaceuticals (CRNX), and MorphoSys (MOR). These companies are all part of the "pharmaceutical products" industry. Cronos Group vs. Its Competitors Aurora Cannabis Canopy Growth Organigram Global SNDL Tilray Brands HUTCHMED Immunovant Kymera Therapeutics Crinetics Pharmaceuticals MorphoSys Cronos Group (NASDAQ:CRON) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation, dividends and media sentiment. Do insiders and institutionals believe in CRON or ACB? 8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 7.3% of Cronos Group shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Is CRON or ACB more profitable? Cronos Group has a net margin of 39.69% compared to Aurora Cannabis' net margin of 1.32%. Aurora Cannabis' return on equity of 0.13% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Cronos Group39.69% -0.07% -0.07% Aurora Cannabis 1.32%0.13%0.10% Do analysts rate CRON or ACB? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 Which has more risk & volatility, CRON or ACB? Cronos Group has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500. Which has preferable earnings & valuation, CRON or ACB? Cronos Group has higher earnings, but lower revenue than Aurora Cannabis. Cronos Group is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCronos Group$124.59M6.35$41.08M$0.1315.77Aurora Cannabis$343.29M0.79$1.63M$0.1144.00 Does the media prefer CRON or ACB? In the previous week, Cronos Group and Cronos Group both had 3 articles in the media. Cronos Group's average media sentiment score of 0.91 beat Aurora Cannabis' score of 0.53 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive SummaryAurora Cannabis beats Cronos Group on 9 of the 15 factors compared between the two stocks. Get Cronos Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRON vs. The Competition Export to ExcelMetricCronos GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$798.36M$2.82B$5.74B$9.51BDividend YieldN/A1.78%4.60%3.99%P/E Ratio15.779.0428.1120.03Price / Sales6.35744.02461.37103.88Price / Cash4,491.53166.2336.5559.01Price / Book0.715.168.655.90Net Income$41.08M$30.99M$3.25B$258.66M7 Day Performance1.99%7.74%4.20%2.23%1 Month Performance8.47%16.18%10.82%12.76%1 Year Performance-15.29%-1.03%34.70%19.36% Cronos Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRONCronos Group2.0405 of 5 stars$2.05-1.0%N/A-12.7%$798.36M$124.59M15.77450News CoverageACBAurora Cannabis0.2832 of 5 stars$4.70+3.8%N/A-16.5%$264.38M$246.72M42.731,130CGCCanopy Growth0.3507 of 5 stars$1.12+2.8%N/A-84.8%$205.93M$225.65M-0.283,150OGIOrganigram Global1.3259 of 5 stars$1.46+0.7%N/A-7.1%$195.55M$117.47M14.60860Positive NewsSNDLSNDL1.8885 of 5 stars$1.58+2.6%$4.00+153.2%-30.8%$415.19M$671.81M-5.452,516News CoverageUpcoming EarningsTLRYTilray Brands1.8105 of 5 stars$0.67+8.4%$1.92+184.6%-60.7%$677.88M$788.94M-0.642,650Upcoming EarningsOptions VolumeHCMHUTCHMED2.7778 of 5 stars$17.74+0.9%$19.00+7.1%-5.1%$3.09B$630.20M0.001,811Positive NewsAnalyst ForecastIMVTImmunovant1.5976 of 5 stars$17.70-1.2%$36.30+105.1%-34.4%$3.03BN/A-6.46120Positive NewsGap DownKYMRKymera Therapeutics3.0325 of 5 stars$45.14-2.3%$59.11+31.0%+6.9%$2.94B$47.07M-14.56170Positive NewsCRNXCrinetics Pharmaceuticals3.6711 of 5 stars$30.95-0.5%$69.50+124.6%-43.1%$2.90B$1.04M-8.10210MORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730 Related Companies and Tools Related Companies ACB Alternatives CGC Alternatives OGI Alternatives SNDL Alternatives TLRY Alternatives HCM Alternatives IMVT Alternatives KYMR Alternatives CRNX Alternatives MOR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRON) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
